Business Context and Reporting Period
This Form 10-Q covers PPG Industries, Inc. for the quarter and six months ended June 30, 1994. PPG is a global manufacturer of paints, coatings, and specialty materials. The reporting period includes the impact of a two-for-one stock distribution effective June 10, 1994, and significant restructuring activities, specifically the divestiture of the Biomedical Systems Division.
Key Financial Metrics
| Metric (Millions) | Q2 1994 | Q2 1993 | 6M 1994 | 6M 1993 |
|---|---|---|---|---|
| Net Sales | $1,619.3 | $1,523.6 | $3,096.2 | $2,970.3 |
| Gross Profit | $631.4 | $557.8 | $1,196.5 | $1,090.5 |
| Gross Margin % | 39.0% | 36.6% | 38.6% | 36.7% |
| Net Income | $96.2 | $106.2 | $218.1 | $(56.5) |
| Earnings Per Share | $0.46 | $0.50 | $1.03 | $(0.27) |
| Cash from Operations (6M) | $241.0 (1994) vs $248.3 (1993) | |||
| Total Debt (Short + Long Term) | $1,150.1 (June 30, 1994) | |||
| Cash and Equivalents | $52.5 (June 30, 1994) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 6.3% in Q2 and 4.2% over six months, driven by higher volumes in Coatings, Glass, and Chemicals segments and the acquisition of Akzo's European auto coatings business.
- Profitability: Gross profit margins improved due to lower manufacturing costs and sales mix gains. However, Q2 net income declined 9.4% year-over-year primarily due to a $52 million after-tax charge for the Biomedical Systems Division divestiture.
- Segment Performance:
- Coatings & Resins: Sales and operating earnings increased significantly.
- Glass: Sales and operating earnings rose due to volume and price increases in North American flat and automotive glass.
- Chemicals: Sales increased, but operating earnings declined due to lower chlor-alkali prices and higher environmental costs.
- Accounting Changes: The 1993 prior-year comparison includes a net charge of $272.8 million related to the adoption of SFAS No. 106 (postretirement benefits) and SFAS No. 109 (income taxes), which distorted the 1993 net income figures.
Guidance, Risks, and Unusual Items
- Divestiture Charge: An $85 million pre-tax charge ($52 million after-tax) was recorded in Q2 1994 related to the exit of the Biomedical Systems Division. This included a reversal of a previously anticipated gain and additional operating losses.
- Environmental Contingencies: PPG maintains $84 million in environmental reserves. Management estimates potential unrecorded exposure between $200 million and $400 million, though these are not considered probable. Resolution is expected over 20+ years.
- Stock Split: A 100% stock distribution was executed in June 1994; all share and per-share data are retroactively adjusted.
- Outlook: Management does not anticipate future annual environmental charges significantly greater than recent years. The company expects to benefit from the elimination of operating losses from divested businesses.
Investor Verification Checklist
- Verify the timeline and expected proceeds from the remaining assets of the Biomedical Systems Division divestiture.
- Monitor the status of the four specific plant sites contributing to the $200-$400 million unrecorded environmental exposure.
- Assess the sustainability of the gross margin improvement given the offsetting effects of inflation and lower chemical prices.
- Review the impact of foreign currency translation on European operations, which negatively impacted sales in the reported period.
- Confirm the integration progress of the Akzo European auto coatings acquisition.